Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Mucosis
company
About
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €3M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Mucosis B.V. is a clinical stage Dutch biotechnology company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth. Mucosis’s lead product candidate is SynGEM:registered:, an intranasal vaccine to prevent respiratory syncytial virus infection. Mucosis' vaccines are based on the patented and validated Mimopath:registered: technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in their proof-of-concept animal and human studies of their FluGEM:registered: vaccine candidate.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€3M $6.90M
Mucosis has raised a total of
€3M $6.90M
in funding over 2 rounds. Their latest funding was raised on
Apr 29, 2014 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 29, 2014 | Series Unknown | $6.90M | 1 | — | — | Detail |
| Sep 10, 2007 | Series A | €3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Mucosis is funded by 1 investors.
MedSciences Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
MedSciences Capital
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
